Lachey, J
Initially approved for the treatment of Type 2 diabetes, its benefits have extended beyond just controlling blood glucose levels and obesity treatment
With our Weight Loss Program , you can see if you might be eligible, understand your options, and visualize what your weight loss could look like while tracking your progress over time
Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)